NIH RFA-DA-25-027: 2024 National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)

Research Category

Funding Type

Internal Deadline

Wednesday, November 8, 2023

Notes

No Applicants // Limit: 1 // Tickets Available: 1

 

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

This notice of funding opportunity (NOFO) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network's capacity torespond to urgent public health needs. The National Institute on Drug Abuse (NIDA) intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, community representatives, healthcare providers, and healthcare institutions.  

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. Application budgets are limited to $500,000 per year in direct costs. Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation.The maximum project period is seven years. 

Program URL

Sponsor

External Deadline

03/14/2024

Solicitation Type

Completed

Year

2023

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now